Evidence map›Paper›PMID 30032287›Full record

ArticleEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery2019

Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids.

Pier Luigi Filosso, Francesco Guerrera, Nicola Rosario Falco, Pascal Thomas, Mariano Garcia Yuste, Gaetano Rocco, Stefan Welter, Paula Moreno Casado, Erino Angelo Rendina, Federico Venuta and 14 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Contralateral metachronous pulmonary carcinoid tumor 7 years after lobectomy.Indian journal of thoracic and cardiovascular surgery · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.Current treatment options in oncology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Growth Rates of Pulmonary Carcinoid Tumors and Hamartomas.Journal of computer assisted tomography
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 19 institutions in 7 countries.

Pier Luigi FilossoDepartment of Thoracic Surgery, University of Torino, Torino, Italy.
Francesco GuerreraDepartment of Thoracic Surgery, University of Torino, Torino, Italy.
Nicola Rosario FalcoUnit of Cancer Epidemiology and CPO Piedmont, San Giovanni Battista Hospital Torino, Torino, Italy.
Pascal ThomasDepartment of Thoracic Surgery, Lung Transplantation and Diseases of the Esophagus, Aix-Marseille University and Hospitals System of Marseille (AP-HM), Marseille, France.
Mariano Garcia YusteDepartment of Thoracic Surgery, University Hospital, Valladolid, Spain.
Gaetano RoccoNational Cancer Institute, Pascale Foundation, Naples, Italy.
Stefan WelterDivision of Thoracic Surgery, Ruhrlandklinik, Essen, Germany.
Paula Moreno CasadoDepartment of Thoracic Surgery, University Hospital 'Reina Sofia', Cordoba, Spain.
Erino Angelo RendinaFondazione Eleonora Lorillard Spencer Cenci, Sapienza University of Rome, Rome, Italy.
Federico VenutaFondazione Eleonora Lorillard Spencer Cenci, Sapienza University of Rome, Rome, Italy.
Luca AmpolliniUnit of Thoracic Surgery, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy.
Mario NosottiUnit of Thoracic Surgery, Ospedale Maggiore Policlinico, University of Milano, Milan, Italy.
Federico RavegliaUnit of Thoracic Surgery, Azienda Ospedaliera S. Paolo, Milan, Italy.
Ottavio RenaUnit of Thoracic Surgery, 'Amedeo Avogadro' University of Eastern Piedmont, Novara, Italy.
Franco StellaUnit of Thoracic Surgery, Policlinico S. Orsola-Malpighi, Bologna, Italy.
Valentina LaroccaUnit of Thoracic Surgery, Ospedale 'Spirito Santo' Azienda ASL di Pescara, Pescara, Italy.
Francesco ArdissoneUnit of Thoracic Surgery, Azienda Ospedaliero-Universitaria 'San Luigi' Orbassano, University of Torino, Torino, Italy.
Alessandro BrunelliDepartment of Thoracic Surgery, St James's University Hospital, Leeds, UK.
Stefano MargaritoraUnit of Thoracic Surgery, Catholic University 'Sacred Heart', Rome, Italy.
William D TravisDepartment of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Dariusz SaganDepartment of Thoracic Surgery, Medical University of Lublin, Lublin, Poland.
Inderpal SarkariaDepartment of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Andrea EvangelistaUnit of Cancer Epidemiology and CPO Piedmont, San Giovanni Battista Hospital Torino, Torino, Italy.
ESTS NETs-WG steering committee
Ospedale San Paolo · ITPiedmont Reference Center for Epidemiology and Cancer Prevention · ITSapienza University of Rome · ITUniversidad de Valladolid · ESUniversity of Turin · ITAix-Marseille Université · FRAzienda USL di Pescara · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITHospital Universitario Reina Sofía · ESIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITMedical University of Lublin · PLMemorial Sloan Kettering Cancer Center · USOspedale di Parma · ITPoliclinico S.Orsola-Malpighi · ITRuhrlandklinik · DESt James's University Hospital · GBUniversità Cattolica del Sacro Cuore · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Pittsburgh Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectivesTypical carcinoids (TCs) are rare, slow-growing neoplasms, usually characterized by satisfactory surgical outcomes. Due to the rarity of TCs, international guidelines for the management of particular clinical presentations currently do not exist. In particular, non-anatomical resections (wedges) are sometimes advocated for Stage 1 TCs because of their indolent behaviour. The aim of this paper was to evaluate the most effective type of surgery for Stage 1 TCs, using the European Society of Thoracic Surgeons retrospective database of the Neuroendocrine Tumors of the Lung Working Group.

methodsWe analysed the effect of surgical procedure on the survival of patients with Stage 1 TCs. Overall survival (OS) was calculated from the date of intervention. The cumulative incidence of cause-specific death (tumour- and non-tumour-related) was also estimated. The impact of the surgical procedure (i.e. lobectomy vs segmentectomy vs wedge resection) on survival was investigated using the Cox model with shared frailty (for OS, accounting for the within-centre correlation) and the Fine and Gray model (for cause-specific mortality) using the approach based on the multinomial propensity score. Effects were estimated including in the model the logit-transformed propensity scores of segmentectomy and wedge resection as covariates.

resultsA total of 876 patients with Stage 1 TCs (569 women, 65%) were included in this study. The median age was 60 years (interquartile range 47-69). At the last follow-up, 66 patients had died: The 5-year OS rate was 94.3% [95% confidence interval (CI) 92.2-95.9]. The 5-year cumulative incidences of tumour- and non-tumour-related deaths were 2.4% (95% CI 1.4-3.9) and 3.9% (95% CI 2.5-5.6%), respectively. The analysis performed using the multinomial propensity score approach confirmed the significantly worse survival of patients treated with a wedge resection compared to those treated with a lobectomy (hazard ratio 2.01, 95% CI 1.09-3.69; P = 0.024). Similar effects of wedge resection are detectable for cause-specific deaths: tumour-related (hazard ratio 2.28, 95% CI 0.86-6.02; P = 0.096) and non-tumour-related (hazard ratio 1.74, 95% CI 0.89-3.40; P = 0.105).

conclusionsIn a large cohort of patients, we were able to demonstrate the superiority of anatomical surgical resection in Stage 1 TCs in terms of OS. This result should therefore be considered for future clinical guidelines for the management of TCs.

Indexed as

Carcinoid TumorLung NeoplasmsPneumonectomyAgedFemaleHumansMaleMiddle AgedRetrospective Studies

Identifiers

PMID30032287
PMCPMC6657278
OpenAlexW2883715038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.